Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea

International Journal of COPD

Volumn 10, Issue , 2015, Pages 497-506

  Lee, Seok Jeong ^a   Kim, Seo Woo ^a   Kong, Kyoung Ae ^a   Ryu, Yon Ju ^a   Lee, Jin Hwa ^a   Chang, Jung Hyun ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Chronic obstructive pulmonary disease; Never smoker; Socioeconomic status

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; KOREA; KOREAN (PEOPLE); LOGISTIC REGRESSION ANALYSIS; LUNG FUNCTION TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONSMOKER; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; UNDERWEIGHT; VERY ELDERLY; AGE; BODY WEIGHT; CHI SQUARE DISTRIBUTION; MIDDLE AGED; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SOCIOECONOMICS; SOUTH KOREA; STATISTICAL MODEL; TUBERCULOSIS, PULMONARY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRONCHIECTASIS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; THINNESS; TUBERCULOSIS, PULMONARY;

EID: 84929401102     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S77662     Document Type: Article

References (55)

1. Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors–United States, 2005–2013. MMWR Surveill Summ. 2014;63(Suppl 4):3–27.
2. D’Souza AO, Shah M, Dhamane AD, Dalal AA. Clinical and economic burden of COPD in a medicaid population. COPD. 2014;11(2):212–220.
3. Brown DW, Pleasants RA. Mortality from chronic obstructive pulmonary disease among adults aged 25 years or older in North Carolina. South Med J. 2011;104(1):20–23.
4. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3–10.
5. Kim DS, Kim YS, Jung KS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med. 2005;172(7):842–847.
6. Zhou Y, Wang C, Yao W, et al. COPD in Chinese nonsmokers. Eur Respir J. 2009;33(3):509–518.
7. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–743.
8. Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest. 2005;128(3):1239–1244.
9. Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139(4):752–763.
10. Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med. 2005;118(12):1364–1372.
11. Sexton P, Black P, Wu L, et al. Chronic obstructive pulmonary disease in non-smokers: a case-comparison study. COPD. 2014;11(1):2–9.
12. Kainu A, Rouhos A, Sovijarvi A, Lindqvist A, Sarna S, Lundback B. COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence. Scand J Public Health. 2013;41(6):570–578.
13. Kanervisto M, Vasankari T, Laitinen T, Heliovaara M, Jousilahti P, Saarelainen S. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105(8):1140–1146.
14. Odencrants S, Bjustrom T, Wiklund N, Blomberg K. Nutritional status, gender and marital status in patients with chronic obstructive pulmonary disease. J Clin Nurs. 2013;22(19–20):2822–2829.
15. Kweon S, Kim Y, Jang MJ, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43(1):69–77.
16. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
17. Matheson MC, Benke G, Raven J, et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax. 2005;60(8):645–651.
18. Yin P, Zhang M, Li Y, Jiang Y, Zhao W. Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health. 2011;11:586.
19. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001;164(3):372–377.
20. Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118(4):981–989.
21. Benedik B, Farkas J, Kosnik M, Kadivec S, Lainscak M. Mini nutritional assessment, body composition, and hospitalisations in patients with chronic obstructive pulmonary disease. Respir Med. 2011;105(Suppl 1):S38–S43.
22. Harik-Khan RI, Fleg JL, Wise RA. Body mass index and the risk of COPD. Chest. 2002;121(2):370–376.
23. Chandra RK. Cell-mediated immunity in nutritional imbalance. Fed Proc. 1980;39(13):3088–3092.
24. Thurlbeck WM. Diaphragm and body weight in emphysema. Thorax. 1978;33(4):483–487.
25. Nizankowska-Mogilnicka E, Mejza F, Buist AS, et al. Prevalence of COPD and tobacco smoking in Malopolska region–results from the BOLD study in Poland. Pol Arch Med Wewn. 2007;117(9):402–410.
26. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881.
27. Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundback B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005;127(5):1544–1552.
28. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935–939.
29. Fullerton DG, Semple S, Kalambo F, et al. Biomass fuel use and indoor air pollution in homes in Malawi. Occup Environ Med. 2009;66(11):777–783.
30. Ekici A, Ekici M, Kurtipek E, et al. Obstructive airway diseases in women exposed to biomass smoke. Environ Res. 2005;99(1):93–98.
31. Liu S, Zhou Y, Wang X, et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax. 2007;62(10):889–897.
32. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2(10):823–860.
33. Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramirez-Sarmiento A, Anto JM, Gea J. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(3):542–546.
34. Bergdahl IA, Toren K, Eriksson K, et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J. 2004;23(3):402–406.
35. Hnizdo E. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2002;156(8):738–746.
36. Omland O, Wurtz ET, Aasen TB, et al. Occupational chronic obstructive pulmonary disease: a systematic literature review. Scand J Work Environ Health. 2014;40(1):19–35.
37. Fingerhut M, Nelson DI, Driscoll T, et al. The contribution of occupational risks to the global burden of disease: summary and next steps. Med Lav. 2006;97(2):313–321.
38. Marchetti N, Garshick E, Kinney GL, et al. Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene. Am J Respir Crit Care Med. 2014;190(7):756–762.
39. Wu CF, Feng NH, Chong IW, et al. Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study. BMC Public Health. 2010;10:44.
40. Lebowitz MD. Influence of passive smoking on pulmonary function: a survey. Prev Med. 1984;13(6):645–655.
41. Brunekreef B, Fischer P, Remijn B, van der Lende R, Schouten J, Quanjer P. Indoor air pollution and its effect on pulmonary function of adult non-smoking women: III. Passive smoking and pulmonary function. Int J Epidemiol. 1985;14(2):227–230.
42. Jaakkola MS, Jaakkola JJ, Becklake MR, Ernst P.: Passive smoking and evolution of lung function in young adults. An 8-year longitudinal study. J Clin Epidemiol. 1995;48(3):317–327.
43. Carey IM, Cook DG, Strachan DP. The effects of environmental tobacco smoke exposure on lung function in a longitudinal study of British adults. Epidemiology. 1999;10(3):319–326.
44. Jaakkola MS, Jaakkola JJ. Effects of environmental tobacco smoke on the respiratory health of adults. Scand J Work Environ Health. 2002;28(Suppl 2):52–70.
45. Noda T, Ojima T, Hayasaka S, Hagihara A, Takayanagi R, Nobutomo K. The health impact of remarriage behavior on chronic obstructive pulmonary disease: findings from the US longitudinal survey. BMC Public Health. 2009;9:412.
46. Kosarev VV, Babanov SA. Age and gender aspect of epidemiology of chronic obstructive pulmonary disease. Adv Gerontol. 2010;23(4):630–635.
47. Hanson C, Rutten EP, Wouters EF, Rennard S. Diet and vitamin D as risk factors for lung impairment and COPD. Transl Res. 2013;162(4):219–236.
48. Jordan TS, Spencer EM, Davies P.: Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology. 2010;15(4):623–628.
49. Pande JN, Jain BP, Gupta RG, Guleria JS. Pulmonary ventilation and gas exchange in bronchiectasis. Thorax. 1971;26(6):727–733.
50. Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12(4):205–209.
51. Tsang KW, Tipoe GL. Bronchiectasis: not an orphan disease in the East. Int J Tuberc Lung Dis. 2004;8(6):691–702.
52. Chung KP, Chen JY, Lee CH, et al. Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis. Clinics (Sao Paulo). 2011;66(4):549–556.
53. Pasipanodya JG, Miller TL, Vecino M, et al. Pulmonary impairment after tuberculosis. Chest. 2007;131(6):1817–1824.
54. Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis. 1971;103(5):625–640.
55. Lee CH, Lee MC, Lin HH, et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One. 2012;7(5):e37978.